share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Welgus Howard G.

SEC ·  Dec 3 13:22

Summary by Moomoo AI

On 12/02/2024, Welgus Howard G. completed the sale of 10,000 shares of Arcutis Biotherapeutics common stock. The transaction was executed at a price of $12.51 per share, resulting in a total transaction value of approximately $125,133. This sale was conducted as an open market or private sale.Following this transaction, Welgus Howard G. holds 161,944 shares of Arcutis Biotherapeutics. The transaction was completed directly by the reporting person, with no indirect holdings involved. The sale reflects a strategic decision by the reporting person, impacting their overall shareholding in the company. Investors may consider this transaction as part of their analysis of insider trading activities within Arcutis Biotherapeutics.
On 12/02/2024, Welgus Howard G. completed the sale of 10,000 shares of Arcutis Biotherapeutics common stock. The transaction was executed at a price of $12.51 per share, resulting in a total transaction value of approximately $125,133. This sale was conducted as an open market or private sale.Following this transaction, Welgus Howard G. holds 161,944 shares of Arcutis Biotherapeutics. The transaction was completed directly by the reporting person, with no indirect holdings involved. The sale reflects a strategic decision by the reporting person, impacting their overall shareholding in the company. Investors may consider this transaction as part of their analysis of insider trading activities within Arcutis Biotherapeutics.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more